TheEdgeResearch
Home / Stocks / JANL

Janel Corporation (JANL)

OTC Industrials Integrated Freight & Logistics
$46.00 ▼ -8.00%
Market Cap
$54.6M
Sector
Industrials
Industry
Integrated Freight & Logistics
Beta
-0.34
52-Wk Range
21-58
CEO
Darren Seirer
Country
US
Currency
USD

Janel Corporation operates in the Integrated Freight & Logistics industry of the Industrials sector, headquartered in New York City, NY, US. The stock last traded at $46.00, down 8.00% on the session, giving a market capitalisation of $54.6M. On trailing twelve-month figures it carries a trailing P/E of 9.98, a net margin of 2.5%. Its beta of -0.34 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
9.98
Price / Sales
0.23
Price / Book
2.00
EV / EBITDA
3.23
Gross margin
31.4%
Operating margin
3.1%
Net margin
2.5%
Return on equity
Debt / equity
0.85
Current ratio
0.79
Dividend yield
0.0%
Payout ratio
28.1%
Company profile
Exchange
Other OTC
Employees
353
IPO date
2003-07-15
Headquarters
New York City, NY, US
About Janel Corporation

Headquartered in New York, NY, Janel Corporation was founded in 1974 and provides a range of services worldwide through its various subsidiaries. The firm adopted its current name in April 2015, previously known as Janel World Trade Ltd. Janel operates across three core business segments: Logistics, Manufacturing, and Life Sciences. The Logistics segment specializes in global cargo movement and supply chain management. This encompasses freight forwarding across air, ocean, and ground modalities, alongside customs brokerage, warehousing, distribution, and supplementary services such as customs filing, cargo insurance procurement, strategic logistics planning, product repackaging, and real-time shipment tracking. Within the Manufacturing division, the company develops and distributes mixing apparatus and equipment catering to diverse industries, including chemicals, inks, paints, construction, plastics, adhesives, cosmetics, food, and pharmaceuticals. Lastly, the Life Sciences segment is dedicated to the production and supply of monoclonal and polyclonal antibodies, diagnostic reagents, and other immunologic reagents crucial for biomedical research. This segment further supports academic and industrial research scientists through antibody manufacturing, and produces items for other life science enterprises on an original equipment manufacturer (OEM) basis.

Comparable companies

Janel Corporation is most often compared with the following Industrials names:

APEUFAQUEFGNOLFKMNCFROOOFSUNTFTTNMFVIAAYWHWRFYJGJ
More research on JANL
JANL technical analysis JANL TheEdge Score Compare against peers
Open full interactive analysis & DCF →